.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Merck
Argus Health
Deloitte
McKesson
Federal Trade Commission
Daiichi Sankyo
Cantor Fitzgerald
Johnson and Johnson
Covington

Generated: June 29, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,790,145

« Back to Dashboard

Details for Patent: 7,790,145

Title:Respiratory dispersion for metered dose inhalers
Abstract: A respiratory dispersion is provided for the pulmonary delivery of at least two bioactive agents. The dispersion comprises a propellant suspension medium having dispersed therein a plurality of perforated microstructures, wherein the two bioactive agents are incorporated into individual perforated microstructures.
Inventor(s): Weers; Jeffry G. (San Diego, CA), Schutt; Ernest G. (San Diego, CA), Dellamary; Luis A. (San Marcos, CA), Tarara; Thomas E. (San Diego, CA), Kabalnov; Alexey (Corvallis, OR)
Assignee: Novartis AG (Basel, CH)
Filing Date:Feb 05, 2008
Application Number:12/012,827
Claims:1. A respiratory dispersion for the pulmonary delivery of at least two bioactive agents, the dispersion comprising a propellant suspension medium having dispersed therein a plurality of perforated microstructures, wherein the two bioactive agents are incorporated into individual perforated microstructures.

2. A respiratory dispersion of claim 1 wherein at least one of the bioactive agents is a bronchodilator.

3. A respiratory dispersion of claim 2 wherein the bronchodilator comprises one or more bronchodilators selected from the group consisting of ephedrine, adrenaline, fenoterol, formoterol, isoprenaline, metaproterenol, salbutamol, albuterol, salmeterol, and terbutaline.

4. A respiratory dispersion of claim 2 wherein at least one of the bioactive agents is an anti-inflammatory agent.

5. A respiratory dispersion of claim 4 wherein the anti-inflammatory agent comprises an anti-inflammatory steroid.

6. A respiratory dispersion of claim 4 wherein the anti-inflammatory agent comprises one or more anti-inflammatory agents selected from the group consisting of fluticasone, beclomethasone, flunisolide, budesonide, tripedane, cortisone, prednisone, prednisolone, dexamethoasone, betamethasone or triamcinalone.

7. A respiratory dispersion of claim 2 wherein at least one of the bioactive agents is an anti-infective agent.

8. A respiratory dispersion of claim 7 wherein the anti-infective agent comprises one or more anti-infective agents selected from the group consisting of a cephalosporin, a macrolide, a quinoline, penicillin, streptomycin, sulphonamide, tetracycline and pentamidine.

9. A respiratory dispersion of claim 7 wherein the anti-infective agent comprises gentamicin.

10. A respiratory dispersion of claim 1 wherein at least one of the bioactive agents is an anti-inflammatory agent.

11. A respiratory dispersion of claim 10 wherein the anti-inflammatory agent comprises one or more anti-inflammatory agents selected from the group consisting of fluticasone, beclomethasone, flunisolide, budesonide, tripedane, cortisone, prednisone, prednisolone, dexamethoasone, betamethasone or triamcinalone.

12. A respiratory dispersion of claim 10 wherein at least one of the bioactive agents is an antineoplastic agent.

13. A respiratory dispersion of claim 10 wherein at least one of the bioactive agents is an antihistamine agent.

14. A respiratory dispersion of claim 10 wherein at least one of the bioactive agents is an anti-infective agent.

15. A respiratory dispersion of claim 14 wherein the anti-infective agent comprises one or more anti-infective agents selected from the group consisting of a cephalosporin, a macrolides, a quinolines, penicillin, streptomycin, a sulphonamides, tetracycline and pentamidine.

16. A respiratory dispersion of claim 15 wherein the anti-infective agent comprises gentamicin.

17. A respiratory dispersion of claim 10 wherein at least one of the bioactive agents is an antitubercular agent.

18. A respiratory dispersion of claim 1 wherein one of the bioactive agents comprises beclomethasone.

19. A respiratory dispersion of claim 1 wherein one of the bioactive agents comprises formoterol.

20. A respiratory dispersion of claim 1 wherein one of the bioactive agents comprises beclomethasone diproprionate and wherein one of the bioactive agents comprises formoterol.

21. A respiratory dispersion of claim 1 wherein one of the bioactive agents comprises budesonide and wherein one of the bioactive agents comprises formoterol.

22. A respiratory dispersion of claim 1 wherein one of the bioactive agents comprises fluticasone and wherein one of the bioactive agents comprises salmeterol.

23. A respiratory dispersion of claim 1 wherein one of the bioactive agents comprises fluticasone and wherein one of the bioactive agents comprises formoterol.

24. A respiratory dispersion of claim 1 wherein one of the bioactive agents comprises beclomethasone and wherein one of the bioactive agents comprises albuterol.

25. A respiratory dispersion of claim 1 wherein one of the bioactive agents is an anti-cholinergic agent.

26. A respiratory dispersion for the pulmonary delivery of a bronchodilator and an anti-inflammatory agent, the dispersion comprising a propellant suspension medium having dispersed therein a plurality of perforated microstructures, wherein the bronchodilator and the anti-inflammatory agent are incorporated into individual perforated microstructures, wherein the bronchodilator comprises one or more bronchodilators selected from the group consisting of ephedrine, adrenaline, fenoterol, formoterol, isoprenaline, metaproterenol, salbutamol, albuterol, salmeterol, and terbutaline and wherein the anti-inflammatory agent comprises one or more anti-inflammatory agents selected from the group consisting of fluticasone, beclomethasone, flunisolide, budesonide, tripedane, cortisone, prednisone, prednisolone, dexamethoasone, betamethasone or triamcinalone.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Fish and Richardson
Boehringer Ingelheim
Chinese Patent Office
Dow
Teva
Harvard Business School
Mallinckrodt
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot